Oncology Reports

1021-335X 1791-2431

D.A. Spandidos

10.3892/or.2026.9207

OR-56-6-09207

Retraction

[Retracted] miR-29a inhibits human retinoblastoma progression by targeting STAT3

Liu

Shu

Zhang

Xiaomeng

Chunmei

Wang

Yingxue

Chunling

122026

08102026

56 6

201

2026

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Rep 39: 739–746, 2018; DOI: 10.3892/or.2017.6144

Following the publication of this paper, and a corrigendum (doi: 10.3892/or.2017.6144) published in 2021 to take account of duplicated western blot data that were identified in Fig. 4D, it has subsequently come to light that flow cytometric plots featured in Fig. 2D and Transwell invasion assay data in Fig. 3B, both on p. 742, contained data that were strikingly similar to data that had already been published in articles written by different research groups at different research institutes in a number of different journals.

Given that the contentious data named above had already been published prior to the receipt of this paper at Oncology Reports, the Editor has decided that this paper should now be retracted from the Journal. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.